BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24837630)

  • 1. In vivo optical imaging of brain tumors and arthritis using fluorescent SapC-DOPS nanovesicles.
    Chu Z; LaSance K; Blanco V; Kwon CH; Kaur B; Frederick M; Thornton S; Lemen L; Qi X
    J Vis Exp; 2014 May; (87):. PubMed ID: 24837630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saposin C coupled lipid nanovesicles specifically target arthritic mouse joints for optical imaging of disease severity.
    Qi X; Flick MJ; Frederick M; Chu Z; Mason R; DeLay M; Thornton S
    PLoS One; 2012; 7(3):e33966. PubMed ID: 22470501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cancer cells using SapC-DOPS nanovesicles.
    Davis HW; Hussain N; Qi X
    Mol Cancer; 2016 May; 15(1):33. PubMed ID: 27160923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors.
    Blanco VM; Chu Z; Vallabhapurapu SD; Sulaiman MK; Kendler A; Rixe O; Warnick RE; Franco RS; Qi X
    Oncotarget; 2014 Aug; 5(16):7105-18. PubMed ID: 25051370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles.
    Blanco VM; Chu Z; LaSance K; Gray BD; Pak KY; Rider T; Greis KD; Qi X
    Oncotarget; 2016 May; 7(22):32866-75. PubMed ID: 27096954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.
    Sun Y; Liou B; Chu Z; Fannin V; Blackwood R; Peng Y; Grabowski GA; Davis HW; Qi X
    EBioMedicine; 2020 May; 55():102735. PubMed ID: 32279952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma.
    Wojton J; Chu Z; Mathsyaraja H; Meisen WH; Denton N; Kwon CH; Chow LM; Palascak M; Franco R; Bourdeau T; Thornton S; Ostrowski MC; Kaur B; Qi X
    Mol Ther; 2013 Aug; 21(8):1517-25. PubMed ID: 23732993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer.
    Chu Z; Abu-Baker S; Palascak MB; Ahmad SA; Franco RS; Qi X
    PLoS One; 2013; 8(10):e75507. PubMed ID: 24124494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas.
    Sulaiman MK; Chu Z; Blanco VM; Vallabhapurapu SD; Franco RS; Qi X
    Mol Cancer; 2015 Apr; 14():78. PubMed ID: 25889084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saposin C coupled lipid nanovesicles enable cancer-selective optical and magnetic resonance imaging.
    Kaimal V; Chu Z; Mahller YY; Papahadjopoulos-Sternberg B; Cripe TP; Holland SK; Qi X
    Mol Imaging Biol; 2011 Oct; 13(5):886-97. PubMed ID: 20838909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SapC-DOPS nanovesicles as targeted therapy for lung cancer.
    Zhao S; Chu Z; Blanco VM; Nie Y; Hou Y; Qi X
    Mol Cancer Ther; 2015 Feb; 14(2):491-8. PubMed ID: 25670331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma.
    Wojton J; Meisen WH; Jacob NK; Thorne AH; Hardcastle J; Denton N; Chu Z; Dmitrieva N; Marsh R; Van Meir EG; Kwon CH; Chakravarti A; Qi X; Kaur B
    Oncotarget; 2014 Oct; 5(20):9703-9. PubMed ID: 25210852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.
    Davis HW; Vallabhapurapu SD; Chu Z; Wyder MA; Greis KD; Fannin V; Sun Y; Desai PB; Pak KY; Gray BD; Qi X
    Cells; 2020 Aug; 9(9):. PubMed ID: 32854321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine.
    Winter PM; Pearce J; Chu Z; McPherson CM; Takigiku R; Lee JH; Qi X
    J Magn Reson Imaging; 2015 Apr; 41(4):1079-87. PubMed ID: 24797437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 4 can recognize SapC-DOPS to stimulate macrophages to express several cytokines.
    Lu K; Zhao G; Lu H; Zhao S; Song Y; Qi X; Hou Y
    Inflamm Res; 2011 Feb; 60(2):153-61. PubMed ID: 20853174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein.
    Qi X; Chu Z; Mahller YY; Stringer KF; Witte DP; Cripe TP
    Clin Cancer Res; 2009 Sep; 15(18):5840-51. PubMed ID: 19737950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence and Bioluminescence Imaging of Orthotopic Brain Tumors in Mice.
    McKinnon E; Moore A; Dixit S; Zhu Y; Broome AM
    Methods Mol Biol; 2017; 1530():283-305. PubMed ID: 28150209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy.
    N'Guessan KF; Patel PH; Qi X
    Cell Commun Signal; 2020 Jan; 18(1):6. PubMed ID: 31918715
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.